Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 102.01% compared to Cronos Group's net margin of -56.43%. Cipher Pharmaceuticals' return on equity of 28.43% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-56.43%	-5.29%	-3.73%
Cipher Pharmaceuticals	102.01%	28.43%	7.90%

Do institutionals and insiders believe in CRON or CPH?

16.0% of Cronos Group shares are owned by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has better valuation & earnings, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$101.78M	10.48	-C$57.37M	-C$0.21	-13.29
Cipher Pharmaceuticals	C$22.16M	17.00	C$22.60M	C$1.25	11.78

Which has more risk & volatility, CRON or CPH?

Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500.

Does the MarketBeat Community believe in CRON or CPH?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 62.20% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%
Cipher Pharmaceuticals	Outperform Votes 181 62.20%	Underperform Votes 110 37.80%

Do analysts recommend CRON or CPH?

Cronos Group presently has a consensus target price of C$3.18, indicating a potential upside of 13.98%. Cipher Pharmaceuticals has a consensus target price of C$12.50, indicating a potential downside of 15.08%. Given Cronos Group's higher possible upside, research analysts plainly believe Cronos Group is more favorable than Cipher Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the media prefer CRON or CPH?

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.00 beat Cipher Pharmaceuticals' score of -0.67 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Neutral
Cipher Pharmaceuticals	Negative

Summary

Cipher Pharmaceuticals beats Cronos Group on 14 of the 19 factors compared between the two stocks.